Annual Cash & Cash Equivalents
$16.23 M
-$58.03 M-78.14%
31 December 2023
Summary:
Singular Genomics Systems annual cash & cash equivalents is currently $16.23 million, with the most recent change of -$58.03 million (-78.14%) on 31 December 2023. During the last 3 years, it has fallen by -$184.82 million (-91.93%). OMIC annual cash & cash equivalents is now -91.93% below its all-time high of $201.05 million, reached on 31 December 2021.OMIC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$52.62 M
+$22.50 M+74.73%
30 September 2024
Summary:
Singular Genomics Systems quarterly cash and cash equivalents is currently $52.62 million, with the most recent change of +$22.50 million (+74.73%) on 30 September 2024. Over the past year, it has increased by +$36.39 million (+224.15%). OMIC quarterly cash and cash equivalents is now -79.55% below its all-time high of $257.27 million, reached on 30 June 2021.OMIC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OMIC Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +224.2% |
| 3 y3 years | -91.9% | -73.8% |
| 5 y5 years | +195.2% | - |
OMIC Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -91.9% | at low | -73.8% | +224.2% |
| 5 y | 5 years | -91.9% | +195.2% | -79.5% | +350.2% |
| alltime | all time | -91.9% | +195.2% | -79.5% | +350.2% |
Singular Genomics Systems Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $52.62 M(+74.7%) |
| June 2024 | - | $30.11 M(+24.9%) |
| Mar 2024 | - | $24.11 M(+48.5%) |
| Dec 2023 | $16.23 M(-78.1%) | $16.23 M(-51.3%) |
| Sept 2023 | - | $33.30 M(-55.5%) |
| June 2023 | - | $74.82 M(-42.1%) |
| Mar 2023 | - | $129.28 M(+74.1%) |
| Dec 2022 | $74.27 M | $74.27 M(-20.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $93.26 M(-39.1%) |
| June 2022 | - | $153.12 M(-18.8%) |
| Mar 2022 | - | $188.57 M(-6.2%) |
| Dec 2021 | $201.05 M(+1620.1%) | $201.05 M(-16.0%) |
| Sept 2021 | - | $239.26 M(-7.0%) |
| June 2021 | - | $257.27 M(+465.1%) |
| Mar 2021 | - | $45.53 M(+289.5%) |
| Dec 2020 | $11.69 M(+112.5%) | $11.69 M |
| Dec 2019 | $5.50 M | - |
FAQ
- What is Singular Genomics Systems annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Singular Genomics Systems?
- What is Singular Genomics Systems quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Singular Genomics Systems?
- What is Singular Genomics Systems quarterly cash and cash equivalents year-on-year change?
What is Singular Genomics Systems annual cash & cash equivalents?
The current annual cash & cash equivalents of OMIC is $16.23 M
What is the all time high annual cash & cash equivalents for Singular Genomics Systems?
Singular Genomics Systems all-time high annual cash & cash equivalents is $201.05 M
What is Singular Genomics Systems quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OMIC is $52.62 M
What is the all time high quarterly cash and cash equivalents for Singular Genomics Systems?
Singular Genomics Systems all-time high quarterly cash and cash equivalents is $257.27 M
What is Singular Genomics Systems quarterly cash and cash equivalents year-on-year change?
Over the past year, OMIC quarterly cash and cash equivalents has changed by +$36.39 M (+224.15%)